肝癌发病率居高不下,隐蔽性强,死亡率高[1]。肝癌治疗仍以手术为主,但中晚期肝癌患者手术风险较大,效果欠佳,因此多采用化疗治疗[2]。我们针对介入联合肿瘤间质综合治疗后肝癌患者的外周血细胞免疫指标变化进行研究,现将结果报告如下。 High incidence of liver cancer, concealment, high mortality [1]. The treatment of liver cancer is still mainly based on surgery, but patients with advanced liver cancer surgery risk is greater, the effect is poor, so the use of chemotherapy [2]. We are investigating the changes of peripheral blood cellular immune indices in patients with hepatocellular carcinoma after interventional treatment of combined tumor mesenchyme, and the results are reported as follows.